Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy

Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved soc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychological medicine 2003-04, Vol.33 (3), p.419-431
Hauptverfasser: GUMLEY, A., O'GRADY, M., MCNAY, L., REILLY, J., POWER, K., NORRIE, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 431
container_issue 3
container_start_page 419
container_title Psychological medicine
container_volume 33
creator GUMLEY, A.
O'GRADY, M.
MCNAY, L.
REILLY, J.
POWER, K.
NORRIE, J.
description Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning. Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N=72) or CBT+TAU (N=72). Participants were prospectively followed up between entry and 12 months. Results. At 12 months, 11 (15·3%) participants in the CBT group were admitted to hospital compared to 19 (26·4%) of the TAU group (hazard ratio=0·53, P=0·10, 95% CI 0·25, 1·10). A total of 13 (18·1%) participants in CBT relapsed compared to 25 (34·7%) in TAU (hazard ratio=0·47, P
doi_str_mv 10.1017/S0033291703007323
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73217841</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291703007323</cupid><sourcerecordid>57147875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-a98ba29231eebc0dddbc0ec81a547371a2ee50c8a58face03967e2518df35a653</originalsourceid><addsrcrecordid>eNqFkVuP0zAQhSMEYsvCD-AFWUjwFvA1dniDalkuK3Hn1Zo6k42XJA52WtF95Y_jqhWVQIgX2_L55mhmTlHcZ_QJo0w__USpELxmmgpKteDiRrFgsqpLU2tzs1js5HKnnxR3UrqilAkm-e3ihHFNWVWJRfHzDGK_JX6cMW5wnH0YSRsiidjDlDALJLnOX4epizh6eJaVtO7nREJLgDBeDmGcOxJhbMLgr7EhLn_E0Pf5OUcP_Y504XL0s98gWWEHGx_WMQtzhxGm7d3iVgt9wnuH-7T48vLs8_JVefHu_PXy-UXplDJzCbVZAa-5YIgrR5umySc6w0BJLTQDjqioM6BMCw6pqCuNXDHTtEJBpcRp8XjvO8XwfY1ptoNPDvseRgzrZPMGmTaS_RdUmklt9M7x4R_gVZ5szENYTqWiQhqZIbaHXAwpRWztFP0AcWsZtbsc7V855poHB-P1asDmWHEILgOPDgAkB32b9-98OnKyklRxnrlyz_k044_fOsRvtspLU7Y6_2C_yhfL9_zNR_s28-LQLAyr6JtLPI7073Z_AVK4xSU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204503484</pqid></control><display><type>article</type><title>Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy</title><source>MEDLINE</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Cambridge University Press Journals Complete</source><creator>GUMLEY, A. ; O'GRADY, M. ; MCNAY, L. ; REILLY, J. ; POWER, K. ; NORRIE, J.</creator><creatorcontrib>GUMLEY, A. ; O'GRADY, M. ; MCNAY, L. ; REILLY, J. ; POWER, K. ; NORRIE, J.</creatorcontrib><description>Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning. Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N=72) or CBT+TAU (N=72). Participants were prospectively followed up between entry and 12 months. Results. At 12 months, 11 (15·3%) participants in the CBT group were admitted to hospital compared to 19 (26·4%) of the TAU group (hazard ratio=0·53, P=0·10, 95% CI 0·25, 1·10). A total of 13 (18·1%) participants in CBT relapsed compared to 25 (34·7%) in TAU (hazard ratio=0·47, P&lt;0·05, 95% CI 0·24, 0·92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities. Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291703007323</identifier><identifier>PMID: 12701663</identifier><identifier>CODEN: PSMDCO</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Behavior therapy. Cognitive therapy ; Biological and medical sciences ; Cognitive Behavioral Therapy ; Cognitive behaviour therapy ; Crisis Intervention ; Early ; Female ; Humans ; Interventions ; Male ; Medical sciences ; Patients ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Randomized controlled trials ; Recurrence ; Relapse ; Schizophrenia ; Schizophrenia - prevention &amp; control ; Schizophrenia - therapy ; Schizophrenic Psychology ; Scotland ; Time Factors ; Treatment Outcome ; Treatments</subject><ispartof>Psychological medicine, 2003-04, Vol.33 (3), p.419-431</ispartof><rights>2003 Cambridge University Press</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-a98ba29231eebc0dddbc0ec81a547371a2ee50c8a58face03967e2518df35a653</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0033291703007323/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,776,780,12826,27903,27904,30978,30979,55606</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14640522$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12701663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GUMLEY, A.</creatorcontrib><creatorcontrib>O'GRADY, M.</creatorcontrib><creatorcontrib>MCNAY, L.</creatorcontrib><creatorcontrib>REILLY, J.</creatorcontrib><creatorcontrib>POWER, K.</creatorcontrib><creatorcontrib>NORRIE, J.</creatorcontrib><title>Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning. Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N=72) or CBT+TAU (N=72). Participants were prospectively followed up between entry and 12 months. Results. At 12 months, 11 (15·3%) participants in the CBT group were admitted to hospital compared to 19 (26·4%) of the TAU group (hazard ratio=0·53, P=0·10, 95% CI 0·25, 1·10). A total of 13 (18·1%) participants in CBT relapsed compared to 25 (34·7%) in TAU (hazard ratio=0·47, P&lt;0·05, 95% CI 0·24, 0·92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities. Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.</description><subject>Behavior therapy. Cognitive therapy</subject><subject>Biological and medical sciences</subject><subject>Cognitive Behavioral Therapy</subject><subject>Cognitive behaviour therapy</subject><subject>Crisis Intervention</subject><subject>Early</subject><subject>Female</subject><subject>Humans</subject><subject>Interventions</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Patients</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Randomized controlled trials</subject><subject>Recurrence</subject><subject>Relapse</subject><subject>Schizophrenia</subject><subject>Schizophrenia - prevention &amp; control</subject><subject>Schizophrenia - therapy</subject><subject>Schizophrenic Psychology</subject><subject>Scotland</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Treatments</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkVuP0zAQhSMEYsvCD-AFWUjwFvA1dniDalkuK3Hn1Zo6k42XJA52WtF95Y_jqhWVQIgX2_L55mhmTlHcZ_QJo0w__USpELxmmgpKteDiRrFgsqpLU2tzs1js5HKnnxR3UrqilAkm-e3ihHFNWVWJRfHzDGK_JX6cMW5wnH0YSRsiidjDlDALJLnOX4epizh6eJaVtO7nREJLgDBeDmGcOxJhbMLgr7EhLn_E0Pf5OUcP_Y504XL0s98gWWEHGx_WMQtzhxGm7d3iVgt9wnuH-7T48vLs8_JVefHu_PXy-UXplDJzCbVZAa-5YIgrR5umySc6w0BJLTQDjqioM6BMCw6pqCuNXDHTtEJBpcRp8XjvO8XwfY1ptoNPDvseRgzrZPMGmTaS_RdUmklt9M7x4R_gVZ5szENYTqWiQhqZIbaHXAwpRWztFP0AcWsZtbsc7V855poHB-P1asDmWHEILgOPDgAkB32b9-98OnKyklRxnrlyz_k044_fOsRvtspLU7Y6_2C_yhfL9_zNR_s28-LQLAyr6JtLPI7073Z_AVK4xSU</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>GUMLEY, A.</creator><creator>O'GRADY, M.</creator><creator>MCNAY, L.</creator><creator>REILLY, J.</creator><creator>POWER, K.</creator><creator>NORRIE, J.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy</title><author>GUMLEY, A. ; O'GRADY, M. ; MCNAY, L. ; REILLY, J. ; POWER, K. ; NORRIE, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-a98ba29231eebc0dddbc0ec81a547371a2ee50c8a58face03967e2518df35a653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Behavior therapy. Cognitive therapy</topic><topic>Biological and medical sciences</topic><topic>Cognitive Behavioral Therapy</topic><topic>Cognitive behaviour therapy</topic><topic>Crisis Intervention</topic><topic>Early</topic><topic>Female</topic><topic>Humans</topic><topic>Interventions</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Patients</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Randomized controlled trials</topic><topic>Recurrence</topic><topic>Relapse</topic><topic>Schizophrenia</topic><topic>Schizophrenia - prevention &amp; control</topic><topic>Schizophrenia - therapy</topic><topic>Schizophrenic Psychology</topic><topic>Scotland</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GUMLEY, A.</creatorcontrib><creatorcontrib>O'GRADY, M.</creatorcontrib><creatorcontrib>MCNAY, L.</creatorcontrib><creatorcontrib>REILLY, J.</creatorcontrib><creatorcontrib>POWER, K.</creatorcontrib><creatorcontrib>NORRIE, J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GUMLEY, A.</au><au>O'GRADY, M.</au><au>MCNAY, L.</au><au>REILLY, J.</au><au>POWER, K.</au><au>NORRIE, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>33</volume><issue>3</issue><spage>419</spage><epage>431</epage><pages>419-431</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><coden>PSMDCO</coden><abstract>Background. The paper describes a randomized controlled trial of targeting cognitive behavioural therapy (CBT) during prodromal or early signs of relapse in schizophrenia. We hypothesized that CBT would result in reduced admission and relapse, reduced positive and negative symptoms, and improved social functioning. Method. A total of 144 participants with schizophrenia or a related disorder were randomized to receive either treatment as usual (TAU) (N=72) or CBT+TAU (N=72). Participants were prospectively followed up between entry and 12 months. Results. At 12 months, 11 (15·3%) participants in the CBT group were admitted to hospital compared to 19 (26·4%) of the TAU group (hazard ratio=0·53, P=0·10, 95% CI 0·25, 1·10). A total of 13 (18·1%) participants in CBT relapsed compared to 25 (34·7%) in TAU (hazard ratio=0·47, P&lt;0·05, 95% CI 0·24, 0·92). In addition, the CBT group showed significantly greater improvement in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities. Conclusions. The study provides evidence for the feasibility and effectiveness for targeting CBT on the appearance of early signs of relapse in schizophrenia. The results are discussed in context of the study's methodological limitations.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>12701663</pmid><doi>10.1017/S0033291703007323</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-2917
ispartof Psychological medicine, 2003-04, Vol.33 (3), p.419-431
issn 0033-2917
1469-8978
language eng
recordid cdi_proquest_miscellaneous_73217841
source MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Cambridge University Press Journals Complete
subjects Behavior therapy. Cognitive therapy
Biological and medical sciences
Cognitive Behavioral Therapy
Cognitive behaviour therapy
Crisis Intervention
Early
Female
Humans
Interventions
Male
Medical sciences
Patients
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Randomized controlled trials
Recurrence
Relapse
Schizophrenia
Schizophrenia - prevention & control
Schizophrenia - therapy
Schizophrenic Psychology
Scotland
Time Factors
Treatment Outcome
Treatments
title Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A26%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20intervention%20for%20relapse%20in%20schizophrenia:%20results%20of%20a%2012-month%20randomized%20controlled%20trial%20of%20cognitive%20behavioural%20therapy&rft.jtitle=Psychological%20medicine&rft.au=GUMLEY,%20A.&rft.date=2003-04-01&rft.volume=33&rft.issue=3&rft.spage=419&rft.epage=431&rft.pages=419-431&rft.issn=0033-2917&rft.eissn=1469-8978&rft.coden=PSMDCO&rft_id=info:doi/10.1017/S0033291703007323&rft_dat=%3Cproquest_cross%3E57147875%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204503484&rft_id=info:pmid/12701663&rft_cupid=10_1017_S0033291703007323&rfr_iscdi=true